v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
CASH FLOW FROM OPERATING ACTIVITIES:    
Net loss $ (1,667,972) $ (2,868,790)
Adjustments to reconcile net loss to net cash used for operating activities:    
Depreciation 43,520 65,014
Amortization of intangible assets 167,785 211,067
Amortization of capitalized contract costs 115,096 134,214
Amortization of note payable 104,166 180,000
Interest payable on note 58,047 72,855
Reserve for inventory (806,488) 0
Operating lease right-of-use assets 34,992 18,939
Share and warrant-based compensation for employees and consultants 131,048 105,985
Stock based directors’ fees 0 20,004
Bad debts 0 15,000
Change in assets and liabilities:    
Accounts receivable (1,134,114) (241,275)
Due from factor 0 74,170
Capitalized contract costs (33,104) (60,665)
Inventory 810,304 (15,869)
Prepaid expenses and other (86,122) (73,727)
Accounts payable (185,548) (162,009)
Accrued liabilities (139,339) (64,355)
Deferred revenue (11,916) (234,731)
Operating lease liabilities (35,037) (13,915)
Net cash used in operating activities (2,634,682) (2,838,088)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Capital expenditures (7,819) (7,373)
Net cash used in investing activities (7,819) (7,373)
CASH FLOW FROM FINANCING ACTIVITIES:    
Proceeds from note payable 0 1,000,000
Offering costs (169,148) (248,783)
Proceeds for exercise of warrants 2,510,436 3,813,057
Receipt of cash from employee stock purchase plan 7,660 876
Repayment of government loan (38,179) (109,137)
Net cash provided by financing activities 2,310,769 4,456,013
Effect of exchange rate changes (143,503) (8,303)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (475,235) 1,602,249
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 2,694,663 437,604
CASH AND CASH EQUIVALENTS, END OF PERIOD 2,219,428 2,039,853
Cash paid for:    
Interest 1,740 1,865
Noncash investing and financing activities    
Additions for operating lease right-of-use assets 119,642
Issuance of stock for repayment of note payable and accrued interest 766,316 1,459,000
Deemed dividends related to warrant inducement $ 4,502,004 $ (0)